Literature DB >> 18422803

The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children.

Matti Korppi1, Massimiliano Don, Francesca Valent, Mario Canciani.   

Abstract

OBJECTIVE: To evaluate the value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children.
DESIGN: A retrospective analysis of clinical signs and symptoms, supplemented with chest radiograph and serum procalcitonin data, in 101 children with community-acquired pneumonia. Viral and bacterial aetiology was studied prospectively by antibody assays, and pneumococcal infection was found in 18, atypical bacterial infection in 28 and viral infection alone in 22 cases.
METHODS: Chest radiographs and serum procalcitonin were studied in all cases. Data on clinical signs and symptoms were retrospectively collected from the medical cards of the patients.
RESULTS: Among symptoms, cough was present in 89% and fever (>37.5 degrees C) in 88% of the cases. Among physical signs, crackles were present in 49% and decreased breath sounds in 58%. No significant associations were found between any of the clinical signs or symptoms and the aetiology of pneumonia. In multivariate analyses, age over 5 years and serum procalcitonin over 1.0 ng/mL were the only independent predictors of bacterial aetiology, but no finding was able to screen between pneumococcal and atypical bacterial aetiology of infection.
CONCLUSION: No clinical or radiological characteristic was helpful in the separation between viral, pneumococcal and atypical bacterial aetiology of community-acquired pneumonia (CAP) in children.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18422803     DOI: 10.1111/j.1651-2227.2008.00789.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  25 in total

1.  Simultaneous use of direct and indirect diagnostic techniques in atypical respiratory infections from Chlamydophila pneumoniae and Mycoplasma pneumoniae.

Authors:  S Pignanelli; A Shurdhi; F Delucca; M Donati
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

2.  Clinical features and inflammatory markers in pediatric pneumonia: a prospective study.

Authors:  Are Stuwitz Berg; Christopher Stephen Inchley; Hans Olav Fjaerli; Truls Michael Leegaard; Morten Lindbaek; Britt Nakstad
Journal:  Eur J Pediatr       Date:  2017-03-09       Impact factor: 3.183

3.  Prediction of delayed recovery from pediatric community-acquired pneumonia.

Authors:  Massimiliano Don; Francesca Valent; Mario Canciani; Matti Korppi
Journal:  Ital J Pediatr       Date:  2010-07-29       Impact factor: 2.638

4.  Procalcitonin predicts response to beta-lactam treatment in hospitalized children with community-acquired pneumonia.

Authors:  Jérémie F Cohen; Alexander Leis; Thibault Lecarpentier; Josette Raymond; Dominique Gendrel; Martin Chalumeau
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

5.  Differentiation between mycoplasma and viral community-acquired pneumonia in children with lobe or multi foci infiltration: a retrospective case study.

Authors:  Wan-Liang Guo; Jian Wang; Li-Yuan Zhu; Chuang-Li Hao
Journal:  BMJ Open       Date:  2015-01-16       Impact factor: 2.692

6.  Sensitivity and Specificity of Soluble Triggering Receptor Expressed on Myeloid Cells-1, Midregional Proatrial Natriuretic Peptide and Midregional Proadrenomedullin for Distinguishing Etiology and to Assess Severity in Community-Acquired Pneumonia.

Authors:  Susanna Esposito; Maria Di Gangi; Fabio Cardinale; Eugenio Baraldi; Ilaria Corsini; Liviana Da Dalt; Pier Angelo Tovo; Antonio Correra; Alberto Villani; Oliviero Sacco; Laura Tenero; Piera Dones; Monia Gambino; Alberto Zampiero; Nicola Principi
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

Review 7.  Biomarkers in Pediatric Community-Acquired Pneumonia.

Authors:  Nicola Principi; Susanna Esposito
Journal:  Int J Mol Sci       Date:  2017-02-19       Impact factor: 5.923

Review 8.  Biomarkers: a definite plus in pneumonia.

Authors:  Hanssa Summah; Jie-Ming Qu
Journal:  Mediators Inflamm       Date:  2009       Impact factor: 4.711

9.  Carers' perspectives on the presentation of community-acquired pneumonia and empyema in children: a case series.

Authors:  Joanna C Crocker; Meirion R Evans; Christopher C Butler; Kerenza Hood; Colin V E Powell
Journal:  BMJ Open       Date:  2012-09-04       Impact factor: 2.692

10.  Differences upon admission and in hospital course of children hospitalized with community-acquired pneumonia with or without radiologically-confirmed pneumonia: a retrospective cohort study.

Authors:  Raquel Simbalista; Dafne C Andrade; Igor C Borges; Marcelo Araújo; Cristiana M Nascimento-Carvalho
Journal:  BMC Pediatr       Date:  2015-10-23       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.